Form 4 Filing for DEXCOM INC (DXCM)

This filing details a Form 4 submission by Jereme M. Sylvain, EVP and Chief Financial Officer of DEXCOM INC. On September 10, 2026, Mr. Sylvain sold 3,638 shares of Common Stock at a price of $83.27 per share, totaling approximately $302,900. This disposition was executed as part of a pre-arranged 10b5-1 plan adopted on June 10, 2026, which allows for the orderly sale of shares. Following this transaction, Mr. Sylvain directly holds 146,828 shares. The filing also notes that the post-transaction share count includes 87,094 unvested restricted stock units, with specific vesting schedules detailed in footnote F2. The transaction code "S" indicates a sale, and the acquired/disposed code "D" signifies a disposition.